Integrative proteomic analyses across common cardiac diseases yield new mechanistic insights and enhanced prediction

Insights

This study analyzed 1,459 proteins in 44,313 UK Biobank participants to find links to heart diseases. Proteomic data improved prediction models for coronary artery disease, heart failure, and atrial fibrillation.

Area of Science:

  • Cardiovascular Science
  • Proteomics
  • Genetics

Background:

  • Cardiac diseases are a major cause of death, with poorly understood molecular underpinnings.
  • Identifying novel molecular mechanisms is crucial for developing effective treatments.

Approach:

  • Leveraged proteomic data from 1,459 circulating proteins in 44,313 UK Biobank participants.
  • Utilized multivariable-adjusted Cox regression and cis-Mendelian randomization to identify protein-disease associations and causal links.
  • Performed interaction analyses to explore sex-specific differences in protein-disease relationships.

Key Points:

  • Identified 820 significant protein-disease associations (441 proteins) for coronary artery disease, heart failure, atrial fibrillation, and aortic stenosis.
  • Cis-Mendelian randomization suggested causal roles for some proteins, highlighting potential therapeutic targets like IL-4 receptor for heart failure.
  • Proteomic data enhanced prediction models for major cardiac conditions compared to clinical risk factors alone.

Conclusions:

  • This large-scale proteomic analysis provides a foundation for understanding cardiac disease mechanisms.
  • Identified potential novel therapeutic targets for various cardiovascular conditions.
  • Suggests the clinical utility of protein-based biomarkers for cardiac disease prevention and risk stratification.

Related Concept Videos

Proteomics01:33

Proteomics

A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
7.3K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
93
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
159